PMKT New$ GERN/STEM/ASTM $tem cells/Geron, GE Healthcare enter stem-cell pact
IT’S ABOUT TIME!!!~~~~~
market pulse
Jun 30, 2009, 7:53 a.m. EST
Geron, GE Healthcare enter stem-cell pact
Stem Cell-Related Stocks Charging Higher in Pre-Bell, Buoyed by Geron’s License Deal with GE Healthcare
06/30 07:39 AM
07:39 AM Eastern Daylight Time, 06/30/2009 (MidnightTrader) — Stocks of companies engaged in stem cell-related research are posting hefty gains on increasing pre-market volume after Geron (GERN:$6.69,00$-0.26,00-3.74%) announced a license deal with GE Healthcare.
Among the issues moving higher are:
GERN, +31%
ASTM, +22%
STEM, +34%
GE Healthcare, a unit of General Electric Company (GE:$11.76,00$0.01,000.09%) , and Geron (GERN:$6.69,00$-0.26,00-3.74%) announced this morning they have entered into a global exclusive license and alliance agreement to develop and commercialize cellular assay products derived from human embryonic stem cells (hESCs) for use in drug discovery, development and toxicity screening. The program will use stem cells derived from hESC lines listed on the NIH Human Pluripotent Stem Cell Registry. Financial terms were not disclosed.
Price: 8.75, Change: +2.06, Percent Change: +30.8


